Trial Profile
A Phase 2, Open-Label, Randomized Multicenter Study for the Development of One-Day Rest/Stress Cardiac Positron Emission Tomography (PET) Perfusion Imaging Protocols of BMS747158
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Flurpiridaz F 18 (Primary)
- Indications Coronary artery disease
- Focus Diagnostic use
- 28 Aug 2014 New trial record